Top compounds associated with response to KRT12


Feature Type Standardized
Nominal ANOVA
mRNA BCL-LZH-4 CTRPv2 pan-cancer AAC -0.027 0.6
mRNA prima-1 CTRPv2 pan-cancer AAC 0.016 0.6
mRNA BRD-K16130065 CTRPv2 pan-cancer AAC 0.036 0.6
mRNA temsirolimus GDSC1000 pan-cancer AAC 0.016 0.6
mRNA BRD-A02303741:carboplatin (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.019 0.6
mRNA navitoclax:birinapant (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.018 0.6
mRNA WZ3105 GDSC1000 pan-cancer AAC 0.014 0.6
mRNA vorinostat:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.017 0.6
mRNA Vandetanib FIMM pan-cancer AAC -0.086 0.6
mRNA Nutlin-3 CTRPv2 pan-cancer AAC -0.017 0.6
Download CSV